ANEB vs INTU · $15.3M cap vs P/E 64, rev $18.83B
Anebulo Pharmaceuticals Inc (ANEB) versus Intuit Inc (INTU) — a side-by-side from cached financials, not a winner call.
Anebulo Pharmaceuticals Inc (ANEB) is a biotechnology company listed on US.
Intuit Inc (INTU) is a software - application company listed on US.
ANEB does not have a complete income-statement cache yet.
Latest reported INTU revenue for 2025-07-31 was $18.83B. Net income was $3.87B. INTU currently screens at market cap $217.76B and trailing P/E 63.7.
ANEB currently screens at market cap $15.3M. INTU currently screens at market cap $217.76B and trailing P/E 63.7.
Not investment advice. Open the ANEB and INTU stock pages for the full models.
Not investment advice.